ALNYLAM PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1679
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 14846
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 132129
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1778
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 15110
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 9129
 
  
 
C07D HETEROCYCLIC COMPOUNDS 9153
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 763
 
  
 
C07K PEPTIDES 6130
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 594

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0064,807 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICSMar 30, 17Mar 08, 18[A61K, C12N, C07D, C07C]
2017/0369,872 REVERSIR TM COMPOUNDSDec 17, 15Dec 28, 17[C12N]
2017/0349,901 HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOFMay 10, 17Dec 07, 17[A61K, C12N]
2017/0304,459 METHODS AND COMPOSITIONS FOR INHALATION DELIVERY OF CONJUGATED OLIGONUCLEOTIDEOct 07, 15Oct 26, 17[A61K, C12N, A61M]
2017/0268,005 COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOFMay 26, 17Sep 21, 17[A61K, C12N, C07K]
2017/0253,874 COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOFMar 06, 17Sep 07, 17[A61K, C12N, C07K]
2017/0131,246 Systems and Methods for IonizationNov 09, 15May 11, 17[G01N]
2017/0045,536 QUANTIFICATION OF TRANSTHYRETIN AND ITS ISOFORMSOct 28, 16Feb 16, 17[G01N]
2016/0376,585 OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATIONJul 11, 14Dec 29, 16[A61K, C12N]
2016/0257,954 SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOFMar 15, 16Sep 08, 16[A61K, C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9902954 Method and medicament for inhibiting the expression of a given geneOct 19, 12Feb 27, 18[A61K, C12N]
9902955 Method and medicament for inhibiting the expression of a given geneMar 18, 14Feb 27, 18[A61K, C12N]
9879261 Serpina1 siRNAs: compositions of matter and methods of treatmentDec 18, 15Jan 30, 18[A61K, C07H, C12N]
9867882 Carbohydrate conjugates as delivery agents for oligonucleotidesAug 25, 15Jan 16, 18[A61K, C07H]
9868950 Lipid formulated compositions and methods for inhibiting expression of serum amyloid A geneNov 04, 15Jan 16, 18[C07H, A61K, C12N]
9850488 Complement component C5 iRNA compositions and methods of use thereofDec 21, 15Dec 26, 17[A61K, C07H, C12N, C07K]
9822365 Compositions and methods for inhibiting expression of the PCSK9 geneJan 25, 16Nov 21, 17[A61K, C07H, C12N]
9796974 Modified RNAi agentsNov 16, 12Oct 24, 17[C12N]
9783806 TMPRSS6 iRNA compositions and methods of use thereofNov 20, 15Oct 10, 17[C07H, A61K, C12N]
9771591 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereofMar 14, 16Sep 26, 17[A61K, C07H, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0121,709 Compositions and Methods for Inhibiting Expression of Factor VAbandonedAug 18, 16May 04, 17[C12N]
2017/0096,663 siRNA Therapy for Transthyretin (TTR) Related Ocular AmyloidosisAbandonedJul 06, 16Apr 06, 17[C12Q, C12N]
2017/0000,815 LIPID FORMULATED DSRNA TARGETING THE PCSK9 GENEAbandonedMar 03, 16Jan 05, 17[A61K, C12N]
2016/0354,404 Compositions and Methods for Inhibition of PCSK9 GenesAbandonedMar 16, 16Dec 08, 16[A61K, C12N]
2016/0312,216 Dual Targeting siRNA AgentsAbandonedOct 16, 15Oct 27, 16[C12N]
2016/0264,963 Compositions and Methods for Inhibiting Expression of TransthyretinAbandonedDec 10, 15Sep 15, 16[A61K, C12N]
2016/0208,261 METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCESAbandonedNov 19, 15Jul 21, 16[C12N]
2016/0186,172 Compositions and methods for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expressionAbandonedNov 12, 15Jun 30, 16[C12N]
2016/0090,593 Lipid Formulated Compositions And Methods For Inhibiting Expression Of Transthyretin (TTR)AbandonedJul 01, 15Mar 31, 16[C12N]
2016/0083,723 USE OF POST-TRANSCRIPTIONAL GENE SILENCING FOR IDENTIFYING NUCLEIC ACID SEQUENCES THAT MODULATE THE FUNCTION OF A CELLAbandonedJun 29, 15Mar 24, 16[C12N]
2016/0076,029 siRNA Therapy for Transthyretin (TTR) Related Ocular AmyloidosisAbandonedJul 23, 15Mar 17, 16[A61K, C12N]
2016/0024,497 Compositions And Methods For Inhibiting Expression Of GSK-3 GenesAbandonedApr 28, 15Jan 28, 16[C12N]
2016/0017,336 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENEAbandonedMay 28, 15Jan 21, 16[C12N]
2016/0017,337 Compositions and Methods for Inhibiting Expression of Eg5 GeneAbandonedMay 22, 15Jan 21, 16[C12N]
2016/0000,819 Compositions and Methods for Inhibiting Expression of Eg5 and VEGF GenesAbandonedApr 09, 15Jan 07, 16[A61K, C12N]
2015/0353,934 Lipid Formulated Compositions and Methods for Inhibiting Expression of a Gene from the Ebola VirusAbandonedApr 13, 15Dec 10, 15[A61K, C12N]
2015/0337,311 Methods And Compositions For Prevention Or Treatment Of RSV Infection Using Modified Duplex RNA MoleculesAbandonedFeb 17, 15Nov 26, 15[C12N]
2015/0240,237 Compositions and Methods for Inhibiting Expression of a Gene from the JC VirusAbandonedMar 12, 15Aug 27, 15[C12N]
2015/0240,242 Compositions And Methods For Inhibiting Expression Of IKK-B GeneAbandonedMar 03, 15Aug 27, 15[C12N]
2015/0232,930 USE OF POST-TRANSCRIPTIONAL GENE SILENCING FOR IDENTIFYING NUCLEIC ACID SEQUENCES THAT MODULATE THE FUNCTION OF A CELLAbandonedMay 06, 15Aug 20, 15[C12Q, G01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.